|
BAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.790800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.138400E-01 |
| Normal-vs-Stage2 |
5.762000E-01 |
| Normal-vs-Stage3 |
6.376200E-02 |
| Normal-vs-Stage4 |
4.949000E-01 |
| Stage1-vs-Stage2 |
9.160800E-01 |
| Stage1-vs-Stage3 |
1.643050E-01 |
| Stage1-vs-Stage4 |
9.148800E-01 |
| Stage2-vs-Stage3 |
2.890200E-01 |
| Stage2-vs-Stage4 |
9.840000E-01 |
| Stage3-vs-Stage4 |
2.451000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.334400E-01 |
| Normal-vs-AfricanAmerican |
4.320200E-01 |
| Normal-vs-Asian |
6.478200E-01 |
| Caucasian-vs-AfricanAmerican |
1.285230E-01 |
| Caucasian-vs-Asian |
6.869400E-01 |
| AfricanAmerican-vs-Asian |
2.553800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.763010E-01 |
| Normal-vs-Female |
3.574600E-01 |
| Male-vs-Female |
5.027400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.218000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.491000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.348030E-01 |
| Normal-vs-Age(81-100Yrs) |
6.957800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.875600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.306400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.385000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.082400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.858600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.560600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.040000E-02 |
| Classical-VS-Follicular |
8.08079999999878E-05 |
| Classical-VS-Other |
2.139000E-01 |
| Classical-VS-Normal |
9.452000E-01 |
| Tall-VS-Follicular |
7.812600E-01 |
| Tall-VS-Other |
9.560600E-01 |
| Tall-VS-Normal |
4.661700E-02 |
| Follicular-VS-Other |
9.225400E-01 |
| Follicular-VS-Normal |
1.127600E-02 |
| Other-VS-Normal |
2.449200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.157800E-01 |
| Normal-vs-N1 |
1.184040E-01 |
| N0-vs-N1 |
5.769000E-01 |
|
|
